Annex 1
Protocol for Novel Coronavirus Pneumonia Case Surveillance
(fourth Version)
Since December 2019, novel coronavirus pneumonia cases have been detected in Wuhan City,
Hubei Province. This Protocol is formulated to provide guidance on timely detection and
reporting of novel coronavirus pneumonia cases in local efforts so as to ensure early detection
and early reporting and prevent the spread of the epidemic.
I. Purpose
1) To timely detect and report the novel coronavirus pneumonia cases, infected persons
and clusters of cases;
2) To understand the characteristics of the epidemic situation of novel coronavirus
infections in the country so as to assess in a timely manner the epidemic trend.
II. Surveillance case definition
Provinces outside Hubei
A. Suspect cases
Make comprehensive analysis based on the following epidemiological history and clinical
manifestations:
1.Epidemiological history
1) Travel or residence history in Wuhan and its surrounding areas or other communities
with reported cases within 14 days before the onset of the disease;
2) History of contact with novel coronavirus infected patients (whose were tested positive
for nucleic acid) within 14 days before the onset of the disease;
3) Having contact with patients with fever and respiratory symptoms who are from Wuhan
and its surrounding areas or other communities with reported cases within 14 days before
the onset of the disease;
4) Part of a cluster of cases.
2. Clinical manifestations:
1) Fever and/or respiratory symptoms;
2) Radiological findings of pneumonia;
3) Normal or lower WBC count, or lower lymphocyte count in early stage.
Cases that meet any one of the epidemiological history and any two of the clinical
manifestations, or have all three clinical manifestations if there is no clear epidemiological
history, are defined as suspect cases.
B. Confirmed case
Confirmed case are suspect case with one of the following etiological evidences:
1. Respiratory specimens or blood specimens found nCoV nucleic acid positive on RT-
PCR;
2. Virus gene sequencing of respiratory or blood samples is highly homologous with the
known novel coronavirus.
C. Asymptomatic infected persons
Individuals without clinical symptoms but whose respiratory and other specimens are
tested positive for the novel coronavirus. They are mainly detected through investigation
of clusters of cases and tracking investigation of the infection source.
D. Clusters of cases
Clusters of cases refer to two and more confirmed cases or asymptomatic infected persons
detected in a small group such as a family, a construction site or a workplace within 14
days, with the possibility of human to human transmission due to close contacts or common
exposure.
Hubei Province
A. Suspect cases
Make comprehensive analysis based on the following epidemiological history and clinical
manifestations:
1.Epidemiological history
1) Travel or residence history in Wuhan and its surrounding areas or other communities
with reported cases within 14 days before the onset of the disease;
2) History of contact with novel coronavirus infected patients (whose were tested positive
for nucleic acid) within 14 days before the onset of the disease;
3) Having contact with patients with fever and respiratory symptoms who are from Wuhan
and its surrounding areas or other communities with reported cases within 14 days before
the onset of the disease;
4) Part of a cluster of cases.
2. Clinical manifestations
1) Fever and/or respiratory symptoms;
2) Normal or lower WBC count, or lower lymphocyte count in early stage.
Cases that meet any one of the epidemiological history or have both clinical manifestations
if there is no epidemiological history, are defined as suspect cases.
B. Clinically diagnosed cases
They are suspect cases with radiological findings of pneumonia.
C. Confirmed case
They are clinical diagnosed cases or suspect cases with one of the following etiological
evidences:
1. Respiratory specimens or blood specimens found nCoV nucleic acid positive on RT-
PCR;
2. Virus gene sequencing of respiratory or blood samples is highly homologous with the
known novel coronavirus.
D. Asymptomatic infected persons
Individuals without clinical symptoms but whose respiratory and other specimens are
tested positive for the novel coronavirus. They are mainly detected through investigation
of clusters of cases and tracking investigation of the infection source.
E. Clusters of cases
Clusters of cases refer to two and more confirmed cases or asymptomatic infected persons
detected in a small group such as a family, a construction site or a workplace within 14
days, with the possibility of human to human transmission due to close contacts or common
exposure.
III. Work Content
1. Case detection
1) Healthcare facilities at all levels should raise their awareness of diagnosis and reporting
of novel coronavirus pneumonia cases. Patients with symptoms like fever, cough, shortness
of breath etc. of unknown causes should be asked about any history of travel to or residence
in Wuhan or surrounding areas or other communities with cases reported, whether they
have exposure to patients with fever or respiratory symptoms in the above areas or
communities, whether they are part of a cluster of cases or have been in contact with any
novel coronavirus infected persons within 14 days before onset of the disease.
2) Relevant grassroots organizations should screen those who have travel or residence
history in Wuhan or surrounding areas or communities with cases reported, who have
respiratory symptoms, fever, chills, fatigue, diarrhea, conjunctival congestion etc. within
the past 14 days as high-risk persons, and have their specimens collected and tested by
professional institutions.
2. Case reporting
When healthcare facilities at all levels and of all kinds detect suspect cases, clinically
diagnosed cases (only for Hubei Province), confirmed cases and asymptomatic infection
cases, they should report via the direct online reporting network within 2 hours. The address
box in the infectious disease report card should be filled with the place of residence at the
time of disease onset, and detailed to the village, residence group, community, household
number etc. so that the case can be traced. The CDC should investigate and verify
immediately after receiving the report and complete the three-level review and
confirmation of the reported information through the network within 2 hours. Healthcare
facilities that do not have the capacity of direct online reporting should immediately report
to the local county/district CDC and send out the completed infectious disease reporting
card within 2 hours. The county/district CDC, upon receiving the report, should
immediately make a direct online reporting and any subsequent revision of the information.
When reporting cases online, select "novel coronavirus pneumonia" for the type of disease,
and report as a “suspect case", "clinically diagnosed case (in Hubei Province only)”,
“confirmed case” or “tested positive” for case classification. “Clinical severity” of suspect
cases, clinically diagnosed cases (in Hubei Province only) and confirmed cases should be
classified and reported as “mild”, “moderate”, “severe” or “critical” in accordance with the
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Fifth Version).
“Tested positive” specifically refers to asymptomatic infected persons, and its clinical
severity is "asymptomatic infected person".
The reported "suspect cases" and "clinical diagnosed cases (in Hubei Province only)”
should be promptly corrected to "confirmed cases" or eliminated in accordance with the
laboratory test results. If the reported "asymptomatic infected persons" have clinical
manifestations, they shall be corrected timely as "confirmed cases". "Clinical severity" of
all cases shall be timely amended according to the disease progression, with the most severe
state of the case as its final state.
3. Detection and reporting of incidents
According to the requirements of the National Public Health Emergency Response
Contingency Plan and the National Public Health Emergency Related Information
Reporting and Management Rules (Trial), the index novel coronavirus pneumonia
confirmed case or cluster in the county/district should be reported within two hours by the
local CDC in the jurisdiction through online direct reporting system for public health
emergencies. The incident level can be categorized as "unclassified" for the time being.
The health authority shall classify the incident level based on investigation findings,
subsequent progress, and results of risk assessment, and adjust it in the system, and submit
the initial report, progress report and final report online in a timely manner.
4. Epidemiological investigation
The county/district CDC upon receiving reports of suspect cases, clinically diagnosed cases
(in Hubei Province only), confirmed cases and asymptomatic infected persons, should
complete case investigation within 24 hours, and register the close contacts in a timely
manner. For details, please refer to the Epidemiological Investigation Protocol for Novel
Coronavirus Pneumonia Cases (Fourth Version) and the Protocol for Management of
Close Contacts of Novel Coronavirus Pneumonia Cases (Fourth Version). After
completing the case investigation, the county/district CDC should submit the case
investigation information of confirmed cases and asymptomatic infected persons through
the online direct reporting system in a timely manner.
The county/district CDC should submit the epidemiological investigation and analysis
report to the health authority at the same level and the CDC at a higher level in time.
5. Specimen collection and laboratory testing
Healthcare facilities that admit and treat suspect cases, clinically diagnosed cases (for
Hubei Province only) and clusters of cases should collect relevant clinical specimens of the
cases and send the specimens to the designated local CDC, healthcare facilities or third-
party testing institutions as soon as possible for related pathogenic testing.
The collected clinical specimens include patients' upper respiratory tract specimens (such
as throat swabs, nasal swabs, etc.), lower respiratory tract specimens (such as deep cough
sputum, respiratory tract extracts, bronchial lavage fluid, pulmonary alveoli lavage fluid,
etc.), eye conjunctiva swabs, stool specimens, anticoagulant and serum specimens etc.
Efforts should be made to try to collect respiratory tract specimens (especially lower
respiratory tract specimens) early in the onset of the disease, serum in the acute stage within
7 days of onset and convalescence serum in the third to fourth week after onset.
Specific requirements for clinical specimen collection and laboratory testing are described
in the Technical Protocol for Laboratory Testing of Novel Coronavirus Pneumonia (Fourth
Version).
Specimen collection, transportation, storage and testing are temporarily managed as level
2 highly pathogenic microorganisms, in accordance with the Regulations on Biological
Safety Management of Pathogenic Microbial Laboratories, the Regulations on the
Management of Transportation of Highly Pathogenic Microorganisms or Samples that Can
Infect Humans (Ministry of Health Order No. 45) and other related requirements.
6. Requirements for verification of laboratory test results of clusters of cases
The original specimens of clusters of five or more novel coronavirus pneumonia cases in
each region should be sent to the Chinese Center for Disease Control and Prevention for
verification and confirmation.
Annex 3
Protocol for Management of Close Contacts of Novel Coronavirus
Pneumonia Cases
(Forth Version)
This Protocol was formulated to identify and manage close contacts of Novel
Coronavirus Pneumonia Cases and effectively control the spread of the disease, based on
the current understanding of novel coronavirus pneumonia, the incubation period being up
to 14 days and human-to-human transmission in existence.
I. Definition
Close contacts refer to people who have any of the following unprotected contacts
with suspect cases, clinically diagnosed cases (Hubei Province only) and confirmed cases
after their onset, or with asymptomatic infected people who are tested positive:
1. Those living, studying, working or other close contacts such as working in close
distance, or sharing the same classroom or living in the same room;
2. Health care workers or family members who diagnose, treat, take care of or visit
the case, or other people who have similar close contact with the case, such as those directly
treating and nursing the case, visiting the case or staying in the closed environment where
the case stays, roommates of the case and their carers in the same room;
3. People who are in the same transportation with the case and have close contacts,
including those who have taken care of the patient on the transportation, accompanying
people of the patient (family, colleagues, friends, etc.), or other passengers and crew
members assessed by investigation as having close contacts with cases or asymptomatic
infected persons. See Appendix 1 for methods to assess close contacts in different
transportations.
4. Those assessed by field investigators as meeting criteria of close contacts.
The identified close contacts should be entered into the Registration Form for Close
1
Contacts of Novel coronavirus Pneumonia Cases (see Appendix 2).
II. Requirements in management
(I) Management of close contacts.
This is arranged by local health authorities along with relevant departments. For those
who rejects medical observation, the local public security agency may involve and take
them into mandatory isolation.
1. When individuals are put under medical observation, they should receive verbal or
written notification on the justification, duration, legal basis, issues to note, knowledge of
the disease, name and phone number of contact person and the health care facility that are
responsible for the medical observation.
2. Medical observation can take place in centralized settings. If not feasible, this can
take place at home with closer management of the contacts. The medical observation period
is 14 days after the last unprotected contact with the case or asymptomatic infected person.
The close contacts of a confirmed case or asymptomatic infected person should complete
the 14-day quarantine even if they are tested negative during quarantine. If a suspect case
is cleared, the medical observation of his or her close contacts is thus terminated.
3. Persons under centralized or home-based medical observation should live relatively
independently to minimize contact with co-residents. Adequate cleaning and disinfection
are done to the observation sites to minimize contamination per Technical Protocol for
Disinfecting Specific Locations (2nd Edition). They should not go out during the
observation period. If going out is necessary, approval from the medical observation
management personnel has to be obtained. When going out, the person should wear a
disposable surgical mask and avoid going to crowded places.
4. General contacts (other than close contacts with whom a case has lived, studied or
worked with) who were not in the same plane, train, ferry or other transportation vehicle
with the case should be provided with information on the health risks, the necessity of
seeking medical attention whenever fever, coughing or other respiratory symptom, diarrhea,
2
or conjunctival suffusion develops, and the obligation to provide history of recent activities.
(II) Measures taken during medical observation
1. During medical observation, measures to be taken are:
(1) During the medical observation, a designated health facility staff shall take the
person’s temperature in the morning and evening every day, ask about the person’s health
status, fill in the medical observation record form, provide necessary help and guidance
and fill in the Medical Observation Registration Form for Close Contacts of Novel
coronavirus Pneumonia Cases (Appendix 3). The Daily Report Form for Medical
Observation of Close Contacts of Novel coronavirus Pneumonia Cases (Appendix 4) and
Daily Summary Form for Medical Observations of Close Contacts of Novel coronavirus
Pneumonia Cases (Appendix 5) can be references for local staff to use when consolidating
the data.
(2) The medical observation manager should take precautions in personal protection
per Precaution Protocol for Specific Populations (2nd Edition).
2. During the medical observation, if the person under observation develops any
symptoms (including fever, chill, dry cough, productive cough, nasal congestion,
rhinorrhea, sore throat, headache, weakness, myalgia, joint soreness, shortness of breath,
dyspnea, chest distress, conjunctival suffusion, nausea, vomiting, diarrhea and abdominal
pain), it should be reported immediately to the local health authority, and the person should
be transferred to a designated health care facility according to regulations for diagnosis and
treatment with specimen collected for laboratory testing and screening. If the person is
identified as a suspect case, confirmed care or clinically diagnosed case (for Hubei
Province only), the close contacts should be put under medical observation.
3. Upon the completion of medical observation, if the close contact has no
presentation of any abnormalities, he or she should be lifted from the medical observation.
(III) Locations for centralized medical observation
1. The following criteria should be met in selecting and equipping the premises for
centralized medical observation:
3
(1) Centralized medical observation facilities should be located in a downwind,
relatively isolated area with easy access to transportation system. It should also be away
from densely populated areas (at least 500 meters away in principle). It should not be
located in a health care facility.
(2) Within the facilities for centralized observation, there should be different
functional areas with clear signs such as living areas, supply areas and patient-care areas.
The premise should be properly ventilated, equipped with basic facilities to support normal
living of people under medical observation and easy for implementing regular disinfection
measures.
(3) The premise should have its own septic tank. Sewage should be disinfected before
discharged into the municipal sewage network by treated regularly with chloride agent. The
treated sewage should contain 10 mg/L chloride residue 1.5 hours after the administration
of chloride agent and meet Sewage Discharge Standards for Health Care Facilities
(GB18466-2005). An alternative to stand-alone septic tank is a container exclusive for
excrement collection. It is disposed of only after being disinfected and treated per General
Disinfection Guideline for Epidemic Area (GB19193-2015).
2. Single rooms should be available in the centralized observation premise to
accommodate individuals with respiratory symptoms (fever and cough), diarrhea,
conjunctival suffusion, etc. Their specimens should then be taken for screening testing.
Appendixes
1. Guidance on assessment of close contacts in transportation system
2. Registration Form for Close Contacts of Novel coronavirus Pneumonia Cases
3. Medical Observation Daily Registration Form for Close Contacts of Novel coronavirus
Pneumonia Cases
4. Daily Report Form for Medical Observation of Closely Contacts of Novel coronavirus
Pneumonia Cases
4
5. Daily Summary Form for Medical Observations of Close Contacts of Novel
coronavirus Pneumonia Cases
5
Appendix 1
Guidance on assessment of close contacts in transportation system
1. Airplane
(1) Close contacts are defined as those seated in the same row, within three rows in the front and three rows in the back of the
patient as well as the crew members serving the defined areas in the aircraft. Other passengers are grouped as general contacts.
(2) The definition expands to everyone in the aircraft if it is not equipped with high-efficiency particulate filter.
(3) Other known close contacts of the case.
2. Train
(1) For closed and air-conditioned train, close contacts are all the passengers and crew members who were in the same car of hard
seat or hard sleeper, or in the same compartment of soft sleeper with the patient.
(2) For regular train other than the closed one, passengers in the same compartment of soft sleeper, or the same segment and the
next segments both back and front in the same car of hard seat or hard sleeper as the patient, and the crew members assigned to
these areas are close contacts.
(3) Other known close contacts of the case.
3. Coach
(1) For a closed and air-conditioned coach, all the passengers in the same coach are close contacts.
(2) For a regular coach other than a closed one, passengers in three rows in the front and three rows in the back as well as the driver
are close contacts.
(3) Other known close contacts of the case.
6
4. Ferry
All the passengers in the same cabin as the patient as well as the crew members assigned to this area.
During the contact period, if the passenger already had obvious symptoms like fever, sneezing, coughing or vomiting, he or she
should be classified as a close contact regardless of the duration of the contact.
7
Appendix 2
Registration Form for Close Contacts of Novel coronavirus Pneumonia Cases
Relation First Last Notes
Contact Contact Contact Ways of
Name Gender Age with contact contact (duration of
No.
patient time time frequency place contact
each contact)
1. Contact frequency: ① often ② average ③ occasionally
2. Contact place: ① At home ② Healthcare facility ③ Workplace ④ Entertainment setting ⑤ Other (please specify)
3. Ways of contact: ① Eat together ② Share apartment ③ Share room ④ Share bed ⑤ Work and study in the same room ⑥
Diagnosis and treatment ⑦ In the same ward ⑧ Entertainment activities ⑨ Other (please specify)
8
Appendix 3
Medical Observation Daily Registration Form for Close Contacts of Novel coronavirus Pneumonia Cases
□ suspected □ confirmed name: contact number: date of onset:
Clinical manifestation
Observation
No. Name Gender Age Address Temperature (℃) Cough Short of breath
started (date)
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
Note:
1. This table is to be used by health personnel who are observing the close contacts of novel coronavirus pneumonia cases.
2. Tick √ when there are “cough" and "short of breath" or × when there is no such symptoms.
Organization: Name:
Date: (year/ month/ day)
9
Appendix 4
Daily Report Form for Medical Observation of Closely Contacts of Novel coronavirus Pneumonia Cases
People under medical observation Number of people
developing clinical Conversions Expected
Street / Date when Cumulative Observation
# of discharge manifestations date when
Commu observation number of s on the day
the last close
nity or for the first people
To contact is
Home case started observed To
# New Pending Total New Total asymptomat Total discharged
patient
ic contact
Total -
Note:
1. This form is used by health care workers for consolidating data for reporting.
2. Clinical manifestations: fever, cough, shortness of breath, etc.
3. The cumulative numbers in the table refer to the aggregated numbers since the medical observation starts.
Organization: (health care facility) Name: Date: (year/ month/ day)
1
Appendix 5
Daily Summary Form for Medical Observations of Close Contacts of Novel coronavirus Pneumonia Cases
People under medical observation Number of people
developing clinical Conversions Expected
Date when Cumulative Observation
# of discharge manifestations date when
Catchme observation number of s on the day
the last close
nt for the first people
To contact is
case started observed To
# New Pending Total New Total asymptomat Total discharged
patient
ic contact
Total -
Note:
1. This table can be used by city and district CDCs for statistical summary.
2. Clinical manifestations: fever, cough, shortness of breath, etc.
3. The cumulative numbers in the table refer to the aggregated numbers since the medical observation started.
Organization: CDC Name: Date: (year/ month/day)
11
12
Novel Coronavirus Infection Control Protocol
(Edition 4)
Novel coronavirus belongs to β-type coronavirus and its genetic characteristics are
significantly different from SARSr-CoV and MERSr-CoV. The virus is sensitive to ultraviolet
rays and heat. It can be killed by heating for a time period of 30 minutes at 56°C and lipid solvents
such as ether, 75% ethanol, chlorine-containing disinfectant, peracetic acid and chloroform can
also effectively inactivate the virus. Based on current epidemiological survey and research results,
the incubation period is 1-14 days, mostly 3-7 days. The source of infection is mainly patients
infected by novel coronavirus and asymptomatic infected persons may also become source of
infection. Main transmission routes are droplet transmission and contact transmission. Whether
there exist aerosol and fecal-oral transmission still needs further investigation. All population is
susceptible.
This Protocol is an update on the 3rd Edition of Novel Coronavirus Pneumonia Prevention and
Control Protocol based on the policy that novel coronavirus pneumonia is classified as a category-
B infectious disease but regulated as a category-A infectious disease, current epidemic situation
across China and the latest findings in case epidemiology and clinical researches, in order to
prevent and control the spread of novel coronavirus, strengthen the organization and coordination
of prevention and control relevant institutions, improve the epidemic information surveillance and
reporting to achieve the goal of "early detection, early reporting, early diagnosis, early isolation,
and early treatment", reduce mortality rate, protect people’s safety and health and maintain social
stability.
I. Purposes
Timely detect and report pneumonia cases caused by novel coronavirus, understand the disease
characteristics and exposure history, standardize close contact management, instruct the public and
specific groups on how to well protect themselves, strictly disinfect specific places, effectively
curb the spread in community and reduce the harm caused by novel coronavirus to public health.
II. Scope of application
It is applicable to guide prevention and control work in various places. This Protocol will be
updated in a timely manner based on the changes in the epidemic situation and the assessment
results.
III. Prevention and control measures
1. Improve prevention and control mechanism and strengthen organizational leadership.
Great importance should be attached to the prevention and control of pneumonia outbreaks
caused by the new coronavirus. Under the leadership of the government at the corresponding level,
the health authorities at all levels should strengthen their guidance on the prevention and control
of epidemics, establish technical expert groups, organize the relevant departments to formulate and
improve relevant work and technical protocols in accordance with the principles of “prevention
first, integration of prevention and treatment, scientific guidance, and timely treatment” so as to
standardize the prevention and control measures against the pneumonia outbreak caused by the
new coronavirus. Strengthen joint prevention and control as well as information communication
and interaction of measures between departments, regularly discuss and determine the
development trend of the epidemic and agree on prevention and control policies.
The health authorities at all levels are responsible for the overall guidance of epidemic
control and ensuring the funds and supplies are in place.
CDCs at all levels are responsible for organizing, coordinating, supervising and evaluating
surveillance work, collecting, analyzing, reporting and feedbacking surveillance data; conducting
field investigations, laboratory testing and technical training; conducting public health education
and risk communication. CDCs at all levels should also guide the public and specific groups to
well protect themselves and direct the disinfection work of specific place.
Healthcare facilities at all levels are responsible for case finding and reporting, isolation,
diagnosis, treatment and clinical management, collecting specimens and providing training for
healthcare workers to curb nosocomial infection.
2. Case and emergence detection and reporting.
Health care facilities and CDCs at all levels and of all types should conduct surveillance,
detection and reporting of pneumonia cases (including asymptomatic infected persons ) due to
novel coronavirus in accordance with the Novel coronavirus pneumonia case surveillance
protocol (4th Edition) (see Annex 1).
1) Case detection.
Health care facilities at various levels should be alerted when doing case diagnosis and
reporting in the process of daily monitoring and treatment. For cases with fever and cough
caused by unknown reasons, travel history or suspicious exposure history within 14 days before
the onset of illness should be consulted, whether patients went to the city of Wuhan or its
surrounding areas, whether patients traveled to or resided in a novel coronavirus outbreak
community, or whether patients contacted with other who had fever and cough in the
abovementioned areas or community, whether there exists the possibility of cluster caused illness
or whether patients contacted with confirmed cases.
Primary level organizations should put more efforts on screening people who travelled to or
resided in Wuhan and its surrounding areas within recent 14 days, people who travelled to or
resided in communities where confirmed cases have been reported and people who have
respiratory symptoms, fever, chills, fatigue, diarrhea, conjunctival congestion and so forth. These
people are key risk groups for screening. Their sampling and testing should be performed by
professional institutions.
2) Case reporting.
When Suspect cases, clinically diagnosed cases (for Hubei Province only), confirmed cases
and asymptomatic cases of novel coronavirus pneumonia are detected, healthcare facilities should
report cases immediately via online reporting system. Those without such capacity should make a
prompt report to local county/district CDC and send out the notifiable disease reporting cards
within 2 hours. Local county/district CDCs should make direct online report upon receiving the
notification. According to Novel coronavirus pneumonia case surveillance protocol (4th edition),
healthcare facilities or CDCs which are responsible for case reporting shall make corrections to
information such as case classification and clinical severity in a timely manner based on laboratory
test results and progress of disease.
3) Detection and reporting of emergencies
Index novel coronavirus pneumonia case in each county/district and case clusters meeting the
case definition of clustered cases set out in the Protocol of Novel Coronavirus Pneumonia Case
Surveillance (4th Edition) should be reported online by the local CDC within 2 hours through the
public health emergency reporting system with the severity level temporarily classified as
“unclassified”. The severity level of the emergency shall be adjusted by the health authority adjust
the later based on the investigation and follow up findings after the risk assessment done.
3. Epidemiological investigation.
County/district CDCs upon receiving reports of Suspect cases, clinically diagnosed cases (for
Hubei Province only), confirmed cases, asymptomatic cases and cluster epidemic from healthcare
facilities or health care workers in their jurisdiction should conduct investigation according to the
Protocol of Epidemiological Investigation of Novel Coronavirus Pneumonia (Fourth Edition)
(See Annex 2) with 24 hours.
County/district CDCs shall submit individual case investigation forms to superior institutions
via infectious disease online reporting information system within 2 hours after completing case
investigation of confirmed cases and asymptomatic infection. At the same time, epidemiological
investigation analysis reports should also be submitted to health administrative department of the
county/district and disease control agency of higher level.
4. Specimen collection and testing.
Healthcare institutions receiving patients should collect relevant clinical specimens and send
the specimens to local designated CDCs, medical facilities or third-party laboratories of testing
institutions as soon as possible to carry out relevant pathogen detection (see Annex 4 for lab
testing protocol).
The clinical specimens include patient’s specimens from the upper respiratory tract (such as
throat swabs, nasal swabs, etc.), lower respiratory tract (such as deep cough sputum, respiratory
tract extracts, bronchial lavage fluid, alveolar lavage fluid, etc.), anticoagulation blood and serum
specimens. Clinical specimens should preferably be respiratory specimens (especially from the
lower respiratory tract) collected in early stage of the case, serum in the acute phase within 7 days
after onset, and convalescent phase serum 3-4 weeks after the onset of disease.
Specimen collection, transportation, storage and testing are temporarily managed per the
protocols for Class II highly pathogenic microorganisms, in accordance with the Regulations on
Biological Safety Management of Pathogenic Microbial Laboratories and Regulations on
Transportation Management of Highly Pathogenic Microorganisms or Samples Infective to
Humans (MoH Order No. 45) and other relevant requirements.
5. Case management and nosocomial infection prevention and control.
Cases should be admitted for treatment to designated healthcare facilities where personnel,
medicines, facilities, equipment and protective supplies required for medical treatment should be
ensured.
Healthcare facilities shall attach great importance to and strengthen the work of isolation,
disinfection and protection according to the requirements of the Technical Guidelines for Novel
Coronavirus Infection Control and Prevention in Healthcare Facilities (1st Edition), fully
implement nosocomial infection control and prevention measures, improve triage of patients, and
strengthen infection control and prevention in fever clinics, emergency rooms and all other general
wards (rooms). Suspect cases, clinically diagnosed cases (for Hubei Province only) and confirmed
cases should be isolated and treated at designated hospitals with effective isolation and protection
conditions. Suspect cases and clinically diagnosed cases (for Hubei Province only) should be
isolated in single rooms. Asymptomatic infected persons should be isolated collectively for 14
days, or they can be released after a 7-day isolation if nucleic acid test result shows negative.
Healthcare facilities shall strictly clean and disinfect medical equipment, contaminated
articles, surfaces and floors, etc. in accordance with the Technical Guidelines for Disinfection in
Healthcare Facilities; perform air disinfection in accordance with the requirements of the
Hospital Air Purification Management Regulations. Medical waste generated during the
diagnosis and treatment of patients with new coronavirus pneumonia should be disposed of and
managed in accordance with the relevant provisions in the Medical Waste Disposal Regulations
and the Measures for Medical Waste Management in Healthcare Facilities.
6. Close contact tracking and management.
Close contact tracing and management should be carried out by county/district health
authorities in conjunction with relevant authorities. Closed contacts of suspect cases, clinically
diagnosed cases (for Hubei Province only), confirmed cases and asymptomatic infected persons
should go under medical observation in collective isolation. Where not feasible, they can be
home quarantined (see Novel coronavirus pneumonia case close contact management protocol
(Version 4) in Annex 3) and their body temperature should be taken at least twice a day and they
should be asked about whether they have any acute respiratory symptoms or other relevant
symptoms or disease progress. The medical observation should last for 14 days after the last
contact with the case or asymptomatic infected person.
7. Public education and risk communication.
Actively carry out public opinion monitoring, disseminate knowledge on epidemic prevention
and control, promptly respond to concerns and questions of the public and conduct risk
communicating in relation to epidemic prevention and control. Health education and risk
communication shall be enhanced for key populations, settings and mass gathering events. In
particular, guide the public and specific groups of personal protection through a variety of ways to
reduce possible contact or exposure (see Personal protection guidelines for certain populations
(Version 2) in Annex 5). At different stages of epidemic development, health education strategies
should be adjusted timely by analysing psychological changes of the public and key information,
and corresponding scientific public education should also be timely organized. Teachers, students
and migrant workers returning back to work should be well informed with health tips and health
management methods.
8. Strengthen training of health professionals in health and medical facilities.
Provide training to health professionals in medical and health facilities on new coronavirus
pneumonia case detection and reporting, epidemiological investigation, specimen collection,
laboratory testing, medical treatment, infection control and prevention, close contact
management and personal protection in order to improve capacities in prevention and control as
well as diagnosis and treatment.
9. Strengthen laboratory testing capacity and raise awareness of biosafety and protection.
Provincial CDCs, prefecture CDCs with laboratory testing capacity, and the designated health
care facilities or the third-party testing agency should formulate laboratory diagnostic methods and
have reagent and technology reserve and stand ready for lab testing at any time in accordance with
laboratory biosafety regulations.
10. Timely disinfection of certain settings.
Specific places such as residences of patients and asymptomatic infected persons , isolation
wards in medical institutions, transfer vehicles and rooms where medical observation takes place
should be disinfected in a timely manner. If needed, disinfection effects of object surfaces, air and
hands should be evaluated timely as well (see Annex 6 ---Technical Protocols for Disinfection in
Certain Places (second edition)).
11. Strengthen prevention and control measures targeting at key settings, institutions and
populations.
Strengthen the multi-sectoral joint prevention and control mechanism to minimize public
gathering activities, and implement measures such as ventilation, disinfection and temperature
taking in places with large population flow such as train stations, airports, ports, shopping malls,
and closed vehicles such as cars, trains, and airplanes.
Strengthen the prevention and control work of collectively living units such as schools and
child care institutions, to perform morning inspection and absence registration due to illness.
Strengthen the prevention and control work in cities with large numbers of migrants and make
preparations for the doubled pressure on prevention and control work due to migrants after the end
of Spring Festival. Strengthen health education for rural migrant workers, students and business
personnel who return home.
12. Categorized community prevention and control.
Different prevention and control strategies should be adopted for communities with different
epidemic situations. For communities where no cases are reported, the strategy of "defense the
external importation cases" should be implemented. For communities where there are cases or
outbreaks, the strategy should be "preventing internal spread and importation from outside”. For
more information, please refer to "Protocol of Community Prevention and Control of Novel
Coronavirus Pneumonia (Trial)” released in the Notice on Strengthening Community Prevention
and Control of Novel Coronavirus Pneumonia” (Pneumonia Mechanism [2020] No. 5).
Annexes:
1. Novel coronavirus pneumonia case surveillance protocol (Version 4)
2. Novel coronavirus pneumonia epi investigation protocol (Version 4)
3. Novel coronavirus pneumonia case close contact management protocol (Version 4)
4. Novel coronavirus pneumonia lab technical guidelines (Version 4)
5. Personal protection guidelines for certain populations (Version 2)
6. Technical protocols for disinfection in certain places (Version 2)
Diagnosis and Treatment Protocol for Novel Coronavirus
Pneumonia
(Trial Version 6, Revised)
Since December 2019, multiple cases of novel coronavirus pneumonia (NCP) have
been identified in Wuhan, Hubei. With the spread of the epidemic, such cases have also
been found in other parts of China and abroad. As an acute respiratory infectious disease,
NCP has been included in class B infectious diseases prescribed in the Law of the People's
Republic of China on Prevention and Treatment of Infectious Diseases, and managed as an
infectious disease of class A. With a better understanding of the epidemic and accumulation
of diagnosis and treatment experience, we now release the Diagnosis and Treatment
Protocol for Novel Coronavirus Pneumonia (Trial Version 6), which is based on the fifth
trial version.
I. Etiological Characteristics
The novel coronaviruses belong to the β genus. They have envelopes, and the particles
are round or oval, often polymorphic, with diameter being 60 to 140 nm. Their genetic
characteristics are significantly different from SARS-CoV and MERS-CoV. Current
research shows that they share more than 85% homology with bat SARS-like coronaviruses
(bat-SL-CoVZC45). When isolated and cultured in vitro, the 2019-nCoV can be found in
human respiratory epithelial cells in about 96 hours, however it takes about 6 days for the
virus to be found if isolated and cultured in Vero E6 and Huh-7 cell lines.
Most of the know-how about the physical and chemical properties of coronavirus
comes from the research on SARS-CoV and MERS-CoV. The virus is sensitive to
ultraviolet and heat. Exposure to 56°C for 30 minutes and lipid solvents such as ether, 75%
ethanol, chlorine-containing disinfectant, peracetic acid, and chloroform can effectively
inactivate the virus. Chlorhexidine has not been effective in inactivating the virus.
II. Epidemiological Characteristics
1. Source of infection
Now, the patients infected by the novel coronavirus are the main source of infection;
asymptomatic infected people can also be an infectious source.
2. Transmission
Transmission of the virus happens mainly through respiratory droplets and close
contact. There is the possibility of aerosol transmission in a relatively closed environment
for a long time exposure to high concentrations of aerosol.
3. Susceptible groups
People are generally susceptible.
III. Clinical Characteristics
1. Clinical manifestations
Based on the current epidemiological investigation, the incubation period is one to
14 days, mostly three to seven days. Main manifestations include fever, fatigue and dry
cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few
cases. Severe cases mostly developed dyspnea and/or hypoxemia after one week. In severe
cases, patients progress rapidly to acute respiratory distress syndrome, septic shock,
metabolic acidosis that is difficult to correct, coagulopathy, multiple organ failure and
others. It is worth noting that for severe and critically ill patients, their fever could be
moderate to low, or even barely noticeable.
The patients with mild symptoms did not develop pneumonia but only low fever
and mild fatigue.
From current situations, most patients have good prognosis and a small number of
patients are critically ill. The prognosis for the elderly and patients with chronic underlying
diseases is poor. Children’s symptoms are relatively mild.
2. Laboratory tests
In the early stages of the disease, peripheral WBC count is normal or decreased and
the lymphocyte count decreases. Some patients see an increase in liver enzymes, lactate
dehydrogenase (LDH), muscle enzymes and myoglobin. Elevated troponin is seen in some
critically ill patients while most patients have elevated C-reactive protein and erythrocyte
sedimentation rate and normal procalcitonin. In severe cases, D-dimer increases and
peripheral blood lymphocytes progressively decrease. Severe and critically ill patients
often have elevated inflammatory factors.
Novel coronavirus nucleic acid can be detected in nasopharyngeal swabs, sputum,
lower respiratory tract secretions, blood, feces and other specimens. In order to increase
the positive rate of nucleic acid detection, it is recommended to take as much sputum as
possible, while lower respiratory tract secretions of patients undergoing tracheal intubation
should be collected, and the specimens should be submitted for examination as soon as
possible after collection.
3. Chest imaging
In the early stage, imaging shows multiple small patchy shadows and interstitial
changes, apparent in the outer lateral zone of lungs. As the disease progresses, imaging
then shows multiple ground glass opacities and infiltration in both lungs. In severe cases,
pulmonary consolidation may occur while pleural effusion is rare.
IV. Case Definitions
1. Suspect cases
Considering both the following epidemiological history and clinical manifestations:
1.1 Epidemiological history
1.1.1 History of travel to or residence in Wuhan and its surrounding areas, or in
other communities where cases have been reported within 14 days prior to the onset of the
disease;
1.1.2 In contact with novel coronavirus infected people (with positive results for
the nucleic acid test) within 14 days prior to the onset of the disease;
1.1.3 In contact with patients who have fever or respiratory symptoms from Wuhan
and its surrounding area, or from communities where confirmed cases have been reported
within 14 days before the onset of the disease; or
1.1.4 A cluster of cases.
1.2 Clinical manifestations
1.2.1 Fever and/or respiratory symptoms;
1.2.2 The aforementioned imaging characteristics of NCP;
1.2.3 Normal or decreased WBC count and decreased lymphocyte count in the early
stage of onset.
A suspect case has any of the epidemiological history plus any two clinical
manifestations or all three clinical manifestations if there is no clear epidemiological
history.
2. Confirmed cases
Suspect cases with one of the following etiological evidence:
2.1 Real-time fluorescent RT-PCR indicates positive for new coronavirus nucleic
acid;
2.2 Viral gene sequence is highly homologous to known new coronaviruses.
V. Clinical Classification
1. Mild cases
The clinical symptoms were mild, and there was no sign of pneumonia on imaging.
2. Moderate cases
Showing fever and respiratory symptoms with radiological findings of pneumonia.
3. Severe cases
Cases meeting any of the following criteria:
3.1 Respiratory distress (≧30 breaths/ min);
3.2 Oxygen saturation≤93% at rest;
3.3 Arterial partial pressure of oxygen (PaO2)/ fraction of inspired oxygen (FiO2)
≦300mmHg (l mmHg=0.133kPa).
PaO2/ FiO2 in high-altitude areas (at an altitude of over 1,000 meters above the sea
level) shall be corrected by the following formula:
PaO2/ FiO2 ✖[Atmospheric pressure (mmHg)/760]
Cases with chest imaging that showed obvious lesion progression within 24-48
hours >50% shall be managed as severe cases.
4. Critical cases
Cases meeting any of the following criteria:
4.1 Respiratory failure and requiring mechanical ventilation;
4.2 Shock;
4.3 With other organ failure that requires ICU care.
VI. Differential Diagnosis
1. The mild manifestations of NCP need to be distinguished from upper respiratory tract
infections caused by other viruses.
2. NCP is mainly distinguished from other known viral pneumonia and mycoplasma
pneumoniae infections such as influenza virus, adenovirus and respiratory syncytial virus.
Especially for suspect cases, methods such as rapid antigen detection and multiplex PCR
nucleic acid detection should be adopted as much as possible for detection of common
respiratory pathogens.
3. It should also be distinguished from non-infectious diseases such as vasculitis,
dermatomyositis and organizing pneumonia.
VII. Case Finding and Reporting
Health professionals in medical institutions of all types and at all levels, upon
discovering suspect cases that meet the definition, should immediately put them in single
room for isolation and treatment. If the cases are still considered as suspected after
consultation made by hospital experts or attending physicians, it should be reported directly
online within 2 hours; samples should be collected for new coronavirus nucleic acid testing
and suspect cases should be safely transferred to the designated hospitals immediately.
People who have been in close contact with patients who have been confirmed of new
coronavirus infection are advised to perform new coronavirus pathogenic testing in a
timely manner, even though common respiratory pathogens are tested positive.
VIII. Treatment
1. Treatment venue determined by the severity of the disease
1.1 Suspected and confirmed cases should be isolated and treated at designated
hospitals with effective isolation, protection and prevention conditions in place. A suspect
case should be treated in isolation in a single room. Confirmed cases can be treated in the
same room.
1.2 Critical cases should be admitted to ICU as soon as possible.
2. General treatment
2.1 Letting patients rest in bed and strengthening support therapy; ensuring
sufficient caloric intake for patients; monitoring their water and electrolyte balance to
maintain internal environment stability; closely monitoring vital signs and oxygen
saturation.
2.2 According to patients’ conditions, monitoring blood routine result, urine routine
result, c-reactive protein (CRP), biochemical indicators (liver enzyme, myocardial enzyme,
renal function etc.), coagulation function, arterial blood gas analysis, chest imaging and
cytokines detection if necessary.
2.3 Timely providing effective oxygen therapy, including nasal catheter and mask
oxygenation, and if necessary, nasal high-flow oxygen therapy.
2.4 Antiviral therapy: Hospitals can try Alpha-interferon (5 million U or
equivalent dose each time for adults, adding 2ml of sterilized water, atomization
inhalation twice daily), lopinavir/ritonavir (200mg/50mg per pill for adults, two pills each
time, twice daily, no longer than 10 days), Ribavirin (suggested to be used jointly with
interferon or lopinavir/ritonavir, 500mg each time for adults, twice or three times of
intravenous injection daily, no longer than 10 days), chloroquine phosphate (500mg for
adults, twice daily, no longer than 10 days), Arbidol (200mg for adults, three times daily,
no longer than 10 days). Be aware of such adverse reactions as lopinavir/ritonavir-related
diarrhea, nausea, vomiting, liver damage, and pay attention to interactions with other
drugs. Further evaluate the efficacy of those drugs currently being used. Do not
recommend using three or more antiviral drugs at the same time; if an intolerable toxic
side effect occurs, the respective drug should be discontinued.
2.5 Antibiotic drug treatment: Blind or inappropriate use of antibiotic drugs
should be avoided, especially in combination with broad-spectrum antibiotics.
3. Treatment of severe and critical cases
3.1 Treatment principle: On the basis of symptomatic treatment, complications
should be proactively prevented, underlying diseases should be treated, secondary
infections also be prevented, and organ function support should be provided timely.
3.2 Respiratory support:
3.2.1 Oxygen therapy: Patients with severe symptoms should receive nasal cannulas
or masks for oxygen inhalation and timely assessment of respiratory distress and/or
hypoxemia should be performed.
3.2.2 High-flow nasal-catheter oxygenation or noninvasive mechanical ventilation:
When respiratory distress and/or hypoxemia of the patient cannot be alleviated after
receiving standard oxygen therapy, high-flow nasal cannula oxygen therapy or non-
invasive ventilation can be considered. If conditions do not improve or even get worse
within a short time (1-2 hours), tracheal intubation and invasive mechanical ventilation
should be used in a timely manner.
3.2.3 Invasive mechanical ventilation: Lung protective ventilation strategy, namely
low tidal volume (4-8ml/kg of ideal body weight) and low inspiratory pressure (platform
pressure <30cmH20) should be used to perform mechanical ventilation to reduce
ventilator-related lung injury. There are many cases of human-machine asynchronization,
therefore sedation and muscle relaxants should be used in a timely manner.
3.2.4 Rescue therapy: Pulmonary re-tensioning is recommended for patients with
severe ARDS. With sufficient human resources, prone position ventilation should be
performed for more than 12 hours per day. If the outcome of prone position ventilation is
poor, extracorporeal membrane oxygenation (ECMO) should be considered as soon as
possible.
3.3 Circulatory support: On the basis of adequate fluid resuscitation, hospitals
should improve microcirculation, use vasoactive drugs and perform hemodynamic
monitoring when necessary.
3.4 Rehabilitation plasma treatment: It is suitable for patients with rapid disease
progression, severe and critically ill patients. Usage and dosage should refer to Clinical
Treatment Plan for Convalescent Patients with NCP during Recovery Phase (first trial
version).
3.5 Other therapeutic measures
For patients with progressive deterioration of oxygenation indicators, rapid
progress in imaging and excessive activation of the body's inflammatory response,
glucocorticoids can be used in a short period of time (three to five days). It is recommended
that dose should not exceed the equivalent of methylprednisolone 1-2 mg/kg/day. Note that
a larger dose of glucocorticoid will delay the removal of coronavirus due to
immunosuppressive effects. Xuebijing 100ml/time can be administered intravenously
twice a day. Intestinal microecological regulators can be used to maintain intestinal
microecological balance and prevent secondary bacterial infections. For critically ill
patients with high inflammatory reactions, extracorporeal blood purification technology
can be considered when conditions permit, such as plasma exchange, adsorption, perfusion,
blood/plasma filtration.
Patients often suffer from anxiety and fear and they should be supported by
psychological counseling.
4. Traditional Chinese Medicine treatment
This disease belongs to the category of plague in traditional Chinese medicine
(TCM), caused by the epidemic pathogenic factors. According to the different local climate
characteristic and individual state of illness and physical conditions, the following
treatment Protocol may vary. The use of over-pharmacopoeia doses should be directed by
a physician.
4.1 During medical observation
Clinical manifestation 1: fatigue and gastrointestinal discomfort
Recommended Chinese patent medicine: Huoxiang Zhengqi capsules (pills,
liquid, or oral solution)
Clinical manifestation 2: fatigue and fever
Recommended Chinese patent medicine: Jinhua Qinggan granules, Lianhua
Qingwen capsules (granules), Shufeng Jiedu capsules (granules), Fangfeng
Tongsheng pills (granules)
4.2 During clinical treatment (confirmed cases)
4.2.1 Lung cleansing & detoxifying decoction
Scope of application: It is suitable for light, moderate and severe patients, and can
be used reasonably in combination with the actual situation of patients in the
treatment of critically ill patients.
Recommended prescription: Ephedra 9g, Zhigancao 6g, Almond 9g, Gypsum 15-
30g (fried first), Guizhi 9g, Zixie 9g, Zhuling 9g, Baizhu 9g, Zhiling 15g,
Bupleurum 16g, Scutellaria baicalensis 6g, and Pinellia 9g , Ginger 9g, aster 9g,
winter flower 9g, shoot dry 9g, asarum 6g, yam 12g, coriander fruit 6g, tangerine
peel 6g, aquilegia 9g.
Suggested use: Traditional Chinese medicine decoction pieces for decocting in
water. One dose per day, twice in the morning and evening (forty minutes after a
meal), take with warm water, and three doses a course.
If conditions permit, the patient can take half a bowl of rice soup each time after
taking the medicine, and can take up to one bowl if the patient has a dry tongue and
is deficient in bodily fluids. (Note: If the patient does not have a fever, the amount
of gypsum should be little. If having a fever or strong heat, the amount of gypsum
can be increased). If the symptoms improve but do not fully recover, then take the
second course of treatment. If the patient has special conditions or other underlying
diseases, the prescription of the second course of treatment can be modified based
on the actual situation and the medicine should be discontinued when the symptoms
disappear.
Source of prescription: Notice on Recommending the Use of ‘Lung cleansing &
detoxifying decoction’ in Treatment of NCP by Integrated Traditional Chinese and
Western Medicine by the Office of the State Administration of Traditional Chinese
Medicine & the General Office of the National Health Commission. (2022 No.22)
4.2.2 Mild cases
4.2.2.1 Cold dampness and stagnation lung syndrome
Clinical manifestations: fever, fatigue, sore body, cough, expectoration, chest
tightness, suffocation, loss of appetite, nausea, vomiting, sticky stools. Tongue has
thin fat tooth mark or is faint red, and the coating is white thick rot or white greasy
and the pulse is moisten or slippery.
Recommended prescription: Raw ephedra 6g, raw gypsum 15g, almond 9g, loquat
15g, gardenia 15g, Guanzhong 9g, Dilong 15g, Xu Changqing 15g, Huoxiang 15g,
Peilan 9g, Cangzhu 15g, Yunling 45g, Atractylodes 30g, Jiao Sanxian 9g each ,
Magnolia officinalis 15g, betel coconut 9g, yarrow fruit 9g, ginger 15g.
Suggested use: one dose daily, boiled with 600ml water, take it three times at
morning, noon and evening before meal.
4.2.2.2 Dampness and heat-accumulation lung syndrome
Clinical manifestations: low or no fever, slight chills, fatigue, heavy head and body,
muscle soreness, dry cough, low phlegm, sore throat, dry mouth, do not want to
drink more, or accompanied by chest tightness, no sweat or sweating, Or vomiting
and loss of appetite, diarrhea or sticky stool. The tongue is reddish, and the coating
is white, thick and greasy or thin yellow, and the pulse is slippery or sloppy.
Recommended prescription: Betel nut 10g, apple 10g, Magnolia 10g, Zhimu 10g,
scutellaria baicalensis 10g, Bupleurum 10g, red peony 10g, forsythia 15g, artemisia
annua 10g (decocted later), 10g of green leaves, 10g of green leaves, 5g of raw
licorice.
Suggested use: one dose daily, boiled with 400ml water, take it twice at morning
and evening.
4.2.3 Moderate cases
4.2.3.1 Dampness and stagnation lung syndrome
Clinical manifestations: fever, low cough and sputum, or yellow sputum,
suffocation, shortness of breath, bloating, and constipation. The tongue is dark red
and fat; the coating is greasy or yellow and the pulse is slippery or stringy.
Recommended prescription: raw ephedra 6g, bitter almond 15g, raw gypsum 30g,
raw coix seed 30g, grass root 10g, patchouli 15g, artemisia annua 12g, Polygonum
cuspidatum 20g, verbena 30g, dried reed root 30g, gardenia 15g 15g of orange red,
10g of raw licorice.
Suggested use: one dose daily, boiled with 400ml water, take it twice at morning
and evening.
4.2.3.2 Cold dampness lung syndrome
Clinical manifestations: low fever, low body temperature, or no heat, dry cough,
low sputum, fatigue, chest tightness, nausea, or nausea. The tongue is pale or red,
and the coating is white or greasy, and the veins are pulsating.
Recommended prescription: Atractylodes lancea 15g, Chenpi 10g, Magnolia 10g,
Aquilegia 10g, grass fruit 6g, raw ephedra 6g, Zhihuo 10g, ginger 10g, betel nut
10g.
Suggested use: one dose daily, boiled with 400ml water, take it twice at morning
and evening.
4.2.4 Severe cases
4.2.4.1 Plague poison and lung-closing syndrome
Clinical manifestations: fever, flushing, cough, yellowish phlegm, or blood in
sputum, wheezing, shortness of breath, tiredness, fatigue, dryness and
stickiness, nausea, food loss, poor stool, and short urination. Red tongue,
yellow greasy coating, slippery pulses.
Recommended prescription: Raw ephedra 6g, almond 9g, raw gypsum 15g,
licorice 3g, fragrant fragrant 10g (back), Magnolia 10g, atractylodes 15g,
grass fruit 10g, pinellia 9g, Poria 15g, raw rhubarb 5g (back) 10g, gardenia
10g, red peony 10g.
Suggested use: one or two doses daily, boiled with 100-200ml water, take it
2-4 times, oral or nasal feeding.
4.2.4.2 Syndrome of flaring heat in qifen and yingfen
Clinical manifestations: Hot fever, thirst, shortness of breath, shortness of
breath, blurred vision, or spotted rash, or vomiting blood, bleeding, or
convulsions in the limbs. Tongue ridges have few or no moss, and the pulse
sinks finely, or floats large and counts.
Recommended prescription: 30-60g gypsum (fried first), 30g of Zhimu, 30-
60g of raw land, 30g of buffalo horn (fried first), 30g of red sage, 30g of black
ginseng, 15g of forsythia, 15g of paeonia, 6g of peony 12g, gardenia 15g, raw
licorice 6g.
Suggested use: 1 dose per day, decoction, first decoct gypsum and buffalo
horn, then apply other pieces, 100ml-200ml each time, 2-4 times a day, orally
or nasally.
Recommended Chinese patent medicines: Xiyanping injection, Xuebijing
injection, Reduning injection, Tanreqing injection, Xingnaojing injection.
Drugs with similar efficacy can be selected according to individual conditions,
or can be used in combination according to clinical symptoms. Traditional
Chinese medicine injection can be used in combination with traditional
Chinese medicine decoction.
4.2.5 Critical cases (syndrome of inner blocking causing collapse)
Clinical manifestations: dyspnea, dyspnea, asthma or need mechanical ventilation,
fainting, irritability, cold sweating, dark purple tongue, thick or dry moss, large
floating roots.
Recommended prescription: 15g of ginseng, 10g of Heishun tablets (decoct first),
15g of dogwood, delivered with Suhexiang Pill or Angong Niuhuang Pill.
Recommended Chinese patent medicines: Xuebijing injection, Reduning injection,
Tanreqing injection, Xingnaojing injection, Shenfu injection, Shengmai injection,
Shenmai injection. Drugs with similar efficacy can be selected according to
individual conditions, or can be used in combination according to clinical
symptoms. Traditional Chinese medicine injection can be used in combination with
traditional Chinese medicine decoction.
Note: Recommended usage of Chinese medicine injections for severe and
critical cases
The use of traditional Chinese medicine injections follows the principle of starting
from a small dose and gradually adjusting the dosage according to the instructions
of the drug. The recommended usage is as follows:
Viral infection or combined mild bacterial infection: 0.9% sodium chloride
injection 250ml plus Xiyanping injection 100mg bid, or 0.9% sodium chloride
injection 250ml heated Duning injection 20ml, or 0.9% sodium chloride injection
250ml plus Tanreqing injection 40ml bid.
High fever with disturbance of consciousness: 250ml of 0.9% sodium chloride
injection and 20ml bid of Xingnaojing injection.
Systemic inflammatory response syndrome or/and multiple organ failure: 250ml of
0.9% sodium chloride injection and 100ml of Xuebijing injection.
Immunosuppression: 250ml of 0.9% sodium chloride injection and 100ml bid of
Shenmai injection.
Shock: 250ml of 0.9% sodium chloride injection plus 100ml bid of Shenfu injection.
4.2.6 Convalescent period
4.2.6.1 Lung and spleen qi deficiency syndrome
Clinical manifestations: shortness of breath, fatigue, fatigue, anorexia, nausea,
fullness, weak stool, and uneasiness. The tongue is pale and greasy.
Recommended prescription: French Pinellia 9g, Chenpi 10g, Codonopsis 15g,
Sunburn Astragalus 30g, Stir-fried Atractylodes 10g, Poria 15g, Huoxiang
10g, Amomum villosum 6g (later), and Licorice 6g
Suggested use: 1 dose per day, boiled with 400ml of water, twice a day at
morning and evening.
4.2.6.2 Qi and Yin deficiency syndrome
Clinical manifestations: Fatigue, shortness of breath, dry mouth, thirst,
palpitations, sweating, poor appetite, low or no lever, dry cough and little
sputum; dry tongue, fine or weak pulses.
Recommended prescription: North and south radix salviae 10g, 15g
ophiopogonis, 6g American ginseng, 6g schisandra, 6g gypsum l5g, 10g light
bamboo leaves, 10g mulberry leaves, 15g reed root, 15g salviae miltiorrhiza,
6g raw liquorice.
Suggested use: 1 dose per day, boiled with 400ml of water, twice a day at
morning and evening.
IX. Isolation Removal and After-discharge Notice
1. Criteria for isolation removal and discharge
1) Body temperature is back to normal for more than three days;
2) Respiratory symptoms improve obviously;
3) Pulmonary imaging shows obvious absorption of inflammation,
4) Nuclei acid tests negative for respiratory tract pathogen twice consecutively (sampling
interval being at least one day).
Those who meet the above conditions can be discharged from isolation.
2. After-discharge notice
2.1 The designated hospitals should contact the primary healthcare facilities where the
patients live and share patients’ medical record, to send the information of the
discharged patients to the community committee and primary healthcare facility where
the patients reside.
2.2. After discharge, due to their low immune function during the recovery phase, the
patients have the risks of infection with other pathogens; it is recommended for
patients to monitor their own health status for 14 days, wear a mask, live in well-
ventilated single room if possible, reduce close contact with family members, separate
dinning, practice hand hygiene and avoid going out.
2.3 It is recommended for the patients to return to the hospitals for follow-up and re-
visit in two and four weeks after discharge.
X. Patients Transportation Principles
Patients should be transported in accordance with the Work Protocol for Transfer
of the Novel Coronavirus Pneumonia Patients (Trial Version) issued by the National
Health Commission.
XI. Nosocomial Infection Prevention and Control
Measures to prevent and control nosocomial infection should be implemented in
accordance with the requirements of the Technical Guidelines for the Prevention and
Control of Infection by the Novel Coronavirus in Medical Institutions (First Edition) and
the Guidelines on the Usage of Common Medical Protective Equipment against Novel
Coronavirus Infection (Trial Version) formulated by the National Health Commission.
The General Office of National Health Commission
Office of State TCM Administration
Printed and distributed on February 18, 2020
(Issued by China CDC)
Contents
A. Prevention and control guidelines for special groups of people
A1. Prevention and control guidelines for the elderly
A2. Prevention and control guidelines for children
A3. Prevention and control guidelines for students
B. Prevention and control guidelines for specific settings
B1. Prevention and control guidelines for kindergartens/schools
B2. Prevention and control guidelines for nursing homes
B3. Prevention and control guidelines for workplaces
B4. Prevention and control guidelines for public transportation
B5. Prevention and control guidelines for public places
B6. Prevention and control guidelines for home quarantine
C. Expert advice
Expert advice on Chinese and Western combined medicine treatment for home-based
patients in the community (Edition 1)
A. Prevention and control guidelines for special groups of people
A1. Prevention and control guidelines for special groups of people: the elderly
1. Ensure that the elderly are aware of personal protection measures against nCoV
infection, hand hygiene requirements, healthy habits and avoiding sharing personal
items, as well as paying attention to ventilation and implementing disinfection
measures. Encourage the elderly to make washing hands regularly their healthy habit.
2. The following measures should be taken if the older person has fever, cough, sore
throat, chest stuffiness, breathing difficulty, fatigue, nausea, vomiting, diarrhea,
conjunctivitis, muscle pain or other suspect symptoms:
(1) Self isolation to avoid close contact with others.
(2) Health assessment is conducted by health care workers who decide if the patient
should be transferred to a healthcare facility for medical care. During the
transportation, the patient should wear surgical masks and avoid riding public
transportation.
(3) People in unprotected close contact with the person with suspect symptoms should
be registered immediately and put under medical observation.
(4) Avoid unnecessary mass gatherings such as parties or dinners; avoid group dinner.
(5) If the older patient with suspect symptoms is confirmed to be a case with nCoV
pneumonia, the close contacts should be put under medical observation for 14 days.
After the patient is evacuated (eg. Hospitalized or dead), timely terminal disinfection
should be conducted in the residence, which should be performed or guided by the
local CDC staff or a qualified third party. It is advised that the residence should not be
used before disinfection.
A2. Prevention and control guidelines for special groups of people: children
1. Avoid getting into crowds of people; avoid mass gathering.
2. Wear masks when going out and remind the parents and grandparents to wear
masks.
3. Keep regular daily schedule with balanced diet. Wash hands before meals and after
toilet. Do physical exercises with parents at home.
4. Foster good respiratory etiquette including covering nose and mouth with tissue or
elbow when sneezing or coughing.
5. Cooperate with parents in seeking medical care timely if having fever or sick.
A3. Prevention and control guidelines for special groups of people: students
1. During winter vacation
(1) Students having lived or travel to outbreak areas (eg Wuhan) should be under
medical observation at home or in a designated place for 14 days after leaving the
outbreak area.
(2) Students in all areas should stay at home as much as possible to minimize visits to
relatives and friends, parties, group dinners and mass gatherings in public places, in
particular poorly ventilated places.
(3) Students are advised to monitor their health status daily and report the result to the
designated person in the community or school following relevant requirements.
(4) Upon the completion of the winter vacation, students without any suspect
symptoms can return to school as usual. Students with suspect symptoms should
report directly or through their guardians to the school, seek medical care timely and
return to school after recovery.
2. On way to school
(1) Wear surgical masks or N95 masks all the time when taking public transportation.
(2) Practise hand hygiene and minimize contacts with common surfaces or articles in
public transportation.
(3) Monitor health status during travel. Take body temperature if you feel having a
fever.
(4) Be cautious about the health status of passengers around you and avoid close
contacts with people with suspect symptoms.
(5) If you develop suspect symptoms during the travel, you should put on surgical
masks or N95 masks, avoid as much as possible contacts with others and seek medical
care based on your medical condition.
(6) When you go to a healthcare facility for medical care during the travel, you should
share with the doctor your travel history to the outbreak area and cooperate with the
doctor in relevant investigation.
(7) Keep good record of your travel documents and tickets in order to cooperate in
any possible close contact investigation.
B. Prevention and control guidelines for specific settings
B1. Prevention and control guidelines for specific settings: kindergartens/schools
1. Students who have lived in or traveled to epidemic areas (such as Wuhan) before
returning to school are advised to have home quarantine for 14 days before returning
to school.
2. After returning to school, students should monitor their body temperature and
health status daily, avoid unnecessary going out as much as possible and avoid contact
with other people.
3. Students in close contact with other teachers and students should wear surgical
masks or N95 masks correctly and minimize the range of their movement.
4. Schools should closely monitor the health status of students by measuring their
body temperature twice a day and making a good record of absences, early departures
and leaves, and report any suspect symptoms to the outbreak manager immediately.
Schools should cooperate with health care facilities in close contact management and
disinfection.
5. Schools should avoid organizing mass gathering activities as much as possible.
Ventilation should be enhanced, and hand sanitizers should be made available in
classrooms, dormitories, libraries, activity centers, canteens, auditorium, teachers'
offices, bathroom and other activity areas.
6. Schools should provide online teaching or catch-up teaching for students who have
missed classes and arrange make-up examinations for the students who have missed
the regular exam, which should not be recorded in the archive.
B2. Prevention and control guidelines for specific settings: nursing homes
It is recommended that nursing homes implement closed-off management during
outbreaks. In principle, visitors are not allowed to get in and the elderly inhabitants
are not allowed to go out; no new admission of the elderly to the nursing home; those
who have gone out should be under close monitoring after return.
1. Daily preventive measures
(1) Ensure the staff and the older people under care are aware of the relevant
information, avoid sharing personal items, pay attention to ventilation, and implement
disinfection measures. Set up health records for the older people and staff and check
and record health status every morning.
(2) Staff developing suspect symptoms should stop duty immediately and seek
medical screening. Only those who have been excluded of with infectious diseases
including nCoV infection can resume duty.
(3) Set up visitor registration system. Visitors with suspect symptoms of nCoV
infection should be rejected for visit. All visitors should wear surgical masks.
(4) Keep good ventilation of the room. Keep the window open for at least 30 minutes
in the morning and in the afternoon. In case opening windows are not feasible,
mechanical ventilation should be installed. In winter windows should be opened with
caution to avoid catching cold due to the difference in indoor and outdoor
temperature.
(5) Encourage the elderly to wash hands regularly and keep the environment tidy and
clean.
(6) Prepare isolation rooms for possible patients with suspect symptoms in the future.
older people with symptoms should be isolated timely to prevent the spread of
infection to others.
2. When an older person has suspect symptoms:
If an older person in the nursing home develops suspect symptoms, the older person
should be isolated timely in a single room, assessed by health professional who shall
decide if the patient should be transferred to a healthcare facility for medical care.
Visits should be suspended.
B3. Prevention and control guidelines for specific settings: workplaces
1. Workers should self-monitor their health status. Stop going to work if any of the
nCoV infection suspect symptoms (including fever, cough, sore throat, chest
stuffiness, breathing difficulty, fatigue, nausea, vomiting, diarrhea, conjunctivitis,
muscle pain, etc.) develops.
2. Persons with suspect symptoms of nCoV infection should be requested by staff to
leave.
3. Commonly used or touched articles or sites should be cleaned and disinfected
regularly.
4. Keep good ventilation in workplaces. Ensure the AC system or exhaust fan in
operation; clean the AC filter regularly; open windows for better ventilation.
5. Make hand sanitizer available all the time in the toilet room; ensure water supply
such as the running water in good operation.
6. Keep good environmental hygiene and dispose of garbage timely.
B4. Prevention and control guidelines for specific settings: public transportation
(including aircrafts, public buses, subways, trains etc.)
1. Public transportation workers in outbreak areas should wear surgical masks or N95
masks and monitor health status on a daily basis.
2. Public transportation is advised to be equipped with thermometer, masks, etc.
3. Increase the frequency of cleaning and disinfection of public transportation; keep
good record of cleaning and disinfection and mark with signs.
4. Keep good ventilation in public transportation.
5. Keep good hygiene in stations and carriages and dispose of garbage timely.
6. Drivers and conductors should work in shifts with a schedule that allows them
enough rest.
B5. Prevention and control guidelines for specific settings: public places
This Guideline is applicable to shopping malls, restaurants, cinemas, KTVs, Internet
cafes, public baths, gymnasiums, exhibition halls, railway stations, subway stations,
airports, bus stations and other public places.
1. Workers in public places should self-monitor their health status and do not come to
work sick if they have suspect symptoms of nCoV infection.
2. Persons with suspect symptoms of nCoV infection should be requested by staff to
leave.
3. Commonly used or touched articles or sites should be cleaned and disinfected
regularly.
4. Keep good ventilation in public places. Ensure the AC system or exhaust fan in
operation; clean the AC filter regularly; open windows for better ventilation.
5. Make hand sanitizer available all the time in the toilet room; ensure water supply
such as the running water in good operation.
6. Keep good environmental hygiene and dispose of garbage timely.
7. In epidemic areas, the public should minimize access to public places, especially to
areas with high population density and poor ventilation.
B6. Prevention and control guidelines for specific settings: home quarantine
1. Arrangement of living space
(1) Persons with suspect symptoms should live in well ventilated single rooms and
decline all visits.
(2) Family members should live in different rooms; if not feasible, they should keep at
least 1 meter apart from each other and sleep in separate beds. Persons with suspect
symptoms should reduce your movement, restrict your own living space, and ensure
good ventilation in shared spaces (such as kitchens and bathrooms) (keep windows
sustainedly open).
2. Arrangement of the carer
Ideally keep one family member as the fixed carer who should be in good health and
free from chronic diseases.
3. Prevention of spread
When a family member stays with the person with suspect symptoms in the same
room, both should wear well and tightly fitted surgical masks. Keep good hand
hygiene; avoid direct contact with body excreta; avoid any contact with anything that
may lead to infections through indirect exposure.
4. Management of contaminated stuff
Used gloves, tissues, masks and other wastes should be put into the designated
garbage bag marked as contaminated before it is disposed of.
5. Stop home quarantine and seek medical care immediately if having any of the
following symptoms:
(1) Breathing difficulty (including worsened chest stuffiness and short of breath after
movement);.
(2) Problems with consciousness (including drowsiness, deliriousness, disorientation,
etc);
(3) Diarrhea.
(4) Body temperature over 39C.
(5) Suspect symptoms of infection with nCoV among other family members.
C. Expert advice on Chinese and Western combined medicine treatment for
home-based patients in the community (Edition 1)
Data available show that since the novel coronavirus pneumonia outbreak in Wuhan,
Hubei Province in December 2019, the major of cases are mild cases. Late winter and
early spring is also the peak time for common cold and flu. As a result, fever clinics
and inpatient departments of hospitals are crowded with patients and visitors. Some
febrile patients may choose home quarantine because of concerns about the risks of
cross infection. This Advice is developed to provide guidance on home quarantine of
febrile patients in accordance with the Protocol of Diagnosis and Treatment of nCoV
Pneumonia (Version 4), Protocol of Prevention and Control of nCoV Pneumonia
(Version 3) and Protocol of Diagnosis and Treatment of Flu (2019).
C1. Advice on screening of febrile patients for home quarantine
In winter and spring, infectious respiratory diseases are common. Common cold, flu
and nCoV pneumonia all can lead to fever, but their symptoms are different. For
instance, common cold is manifested by upper respiratory tract symptoms such as
sneezing, running nose and throat discomfort with mild general symptoms without
fever or very brief fever. Symptoms of influenza include high fever, more severe
systemic symptoms, chills, headache, general pains, blocked nose, running nose, dry
cough, chest pain, nausea, loss of appetite, etc. nCoV pneumonia is characterized by
fever, fatigue and dry cough; a few patients may have symptoms like nasal blockage,
running nose and diarrhea.
With onset of symptoms such as fever and cough, home quarantine is advised for the
following scenarios:
1. Symptoms are mild with body temperature below 38C, no obvious short of breath,
chest stuffiness, breathing difficulty; vital signs such as breathing, blood pressure and
heart rate are stable.
2. Patients have no major underlying respiratory or cardiovascular diseases or severe
obesity.
C2. Advice on medical management of febrile patients under home quarantine
1. Rest; balanced diet; avoid greasy food;
2. Drink warm water and avoid cold water to comfort the digestive system;
3. Avoid inappropriate use of antibiotics;
4. Wear masks correctly; eat meal separately from other family members; keep 1.5
meters away from other family members.
5. Patients with chill may use traditional Chinese patent medicines that are antipyretic
and anti-cold.
6. Patients with chill, fever, muscle pain and cough may use traditional Chinese patent
medicines that can clear heat and toxics and stop coughing.
7. Patients with fatigue, nausea, poor appetite and diarrhea may use traditional
Chinese patent medicines that can relieve moisture.
8. Patients with fever and sore throat may use traditional Chinese patent medicines
that can clear heat and toxics and comfort throat.
9. Patients with fever and inhibited defecation may add drugs that can relax bowel and
discharge heat.
10. If body temperature is over 38.5C, physical cooling measures can be applied such
as wet towels or ice bags. It is advised that patients take oral antipyretic analgesics or
medicines that can clear heat and toxics.
Refer to the Protocol for Diagnosis and Treatment of nCoV Pneumonia (version 4)
for specific recommended medicines.
C3. Home-based prevention and control measures for febrile patients
1. The patient is advised to be under home quarantine for 7 days.
2. Maintain cleanliness and good ventilation in the living environment. Ventilate the
room for half an hour in the morning, at noon and in the evening while keep warm
when doing so.
3. Know how to wear masks correctly; have good respiratory etiquette (covering nose
and mouth with elbow instead of hands when coughing or sneezing); wash hands
frequently (not touching nose, mouth, eyes with unwashed hand); cover the toilet
before flushing.
4. Avoid gatherings and group dinners and minimize the length of stay in crowded
places.
5. Patients with symptoms such as fever or cough should be aware of ways of
self-protection such as isolation in single rooms; if not feasible, patients should keep
at least 1.5 meters away from other family members; keep the door closed all the time
to avoid cross-ventilation among different rooms; avoid using central
air-conditioning.
6. All should wear masks on the way to a hospital for seeking medical care.
7. Masks used by febrile patients should be sealed in a storage bag before being
disposed of into a garbage bin.
C4. Monitoring of symptoms of febrile patients under home quarantine
1. Closely monitor body temperature at least twice a day.
2. Watch for chest stuffiness, short of breath, rapid breathing, increased heart rate etc.
3. Watch if intestinal tract symptoms like diarrhea or vomiting are worsening.
C5. Advice on the management of abnormal symptoms during home quarantine
1. Seek medical care in a designated hospital or a fever clinic if having the following:
(1) Body temperature high for 2 consecutive hours;
(2) Chest stuffiness or short of breath.
2. If breath frequency is or faster than 30 times/minute with breathing difficulty and
cyanosis of lips, call 120 to get emergency care workers to transfer the patient to the
designated hospital or fever clinic for treatment.
The advice is to be revised and improved based on clinical evidences. It is advised to
use it based on the local context.
Saatja: 林 昀 <
[email protected]>
Saadetud: 24.02.2020 10:03
Adressaat: <
[email protected]>; <
[email protected]>;
<
[email protected]>; <
[email protected]>; <
[email protected]>; SM Info
<
[email protected]>; <
[email protected]>; <
[email protected]>; <
[email protected]>;
<
[email protected]>; <
[email protected]>; <
[email protected]>; Kancelaria
<
[email protected]>; <
[email protected]>; <
[email protected]>;
<
[email protected]>; <
[email protected]>
Teema: Relevant technical guidelines for COVID-2019 (Updated)
Manused: Protocols 20200223.zip
Dear colleagues from Central and Eastern European Countries,
Please find attached the updated relevant technical guidelines adopted in China for the current
COVID-2019 outbreak, as attached.
Thank you for your kindness.
Best wishes,
LIN Yun (Ms.)
European and American Affairs
Department of International Cooperation
National Health Commission, China
Tel: +86 10 6879 2502
Fax: +86 10 6879 2285